| Literature DB >> 33918290 |
Luis Gustavo Saboia Ponte1, Isadora Carolina Betim Pavan1,2, Mariana Camargo Silva Mancini1, Luiz Guilherme Salvino da Silva1, Ana Paula Morelli1, Matheus Brandemarte Severino1, Rosangela Maria Neves Bezerra1, Fernando Moreira Simabuco1.
Abstract
Flavonoids represent an important group of bioactive compounds derived from plant-based foods and beverages with known biological activity in cells. From the modulation of inflammation to the inhibition of cell proliferation, flavonoids have been described as important therapeutic adjuvants against several diseases, including diabetes, arteriosclerosis, neurological disorders, and cancer. Cancer is a complex and multifactor disease that has been studied for years however, its prevention is still one of the best known and efficient factors impacting the epidemiology of the disease. In the molecular and cellular context, some of the mechanisms underlying the oncogenesis and the progression of the disease are understood, known as the hallmarks of cancer. In this text, we review important molecular signaling pathways, including inflammation, immunity, redox metabolism, cell growth, autophagy, apoptosis, and cell cycle, and analyze the known mechanisms of action of flavonoids in cancer. The current literature provides enough evidence supporting that flavonoids may be important adjuvants in cancer therapy, highlighting the importance of healthy and balanced diets to prevent the onset and progression of the disease.Entities:
Keywords: cancer; cell signaling; flavonoids
Year: 2021 PMID: 33918290 DOI: 10.3390/molecules26072029
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411